Research
Allosteric inhibition rescues hydrocephalus caused by catalytically inactive Shp2 in mice
PLOS ·
The Brief
- A study in mice reports that allosteric inhibition rescued hydrocephalus caused by a catalytically inactive Shp2 mutation.
- SHP2 is a protein tyrosine phosphatase described in the source as crucial in Ras-MAPK signaling.
- The findings were published in PLOS Biology.
Why it matters
The study shows that an allosteric SHP2 inhibitor reversed a hydrocephalus phenotype in a mouse model, which gives science readers a concrete example of pharmacological rescue of a SHP2-linked brain disorder.
Who’s affected
- researchers in cell signaling and neuroscience
- readers interested in hydrocephalus and its molecular causes
- #shp2
- #hydrocephalus
- #allosteric-inhibition
- #ras-mapk
- #mouse-model
by Neoklis Makrides, Emily Sun, Hilal Mir, Jen-Zen Chuang, Ziyuan Jiang, Yihua Wu, Carlos Serra, John Peregrin, Qian Wang, Wellington V. Cardoso, Ching-Hwa Sung, Neel H. Shah, Xin Zhang SHP2, a protein tyrosine phosphatase (PTP) crucial in Ras-MAPK signaling, is associated with…